Andrew Hollman Meyer

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hollman Meyer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Business Officer Common Stock 82.1K $2.7M $32.85 Mar 3, 2025 Direct
Janux Therapeutics, Inc. Chief Business Officer Stock Option (right to buy) 94K Mar 3, 2025 Direct

Insider Reports Filed by Andrew Hollman Meyer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Mar 3, 2025 4 -$93.1K 4 Mar 5, 2025 Chief Business Officer
JANX Janux Therapeutics, Inc. Feb 3, 2025 5 -$127K 4 Feb 5, 2025 Chief Business Officer
JANX Janux Therapeutics, Inc. Jan 2, 2025 7 -$732K 4 Jan 3, 2025 Chief Business Officer
JANX Janux Therapeutics, Inc. Dec 19, 2024 4 $200K 4 Dec 20, 2024 Chief Business Officer
JANX Janux Therapeutics, Inc. Sep 27, 2024 3 -$2.09M 4 Sep 27, 2024 Chief Business Officer
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 Chief Business Officer
JANX Janux Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Business Officer
JANX Janux Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Business Officer
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Chief Business Officer